Universal Cells
Lisa Petek, a professional with experience in research and core technologies, has worked in various roles at Universal Cells since January 2016. Prior to that, Lisa served as a Research Scientist at the University of Washington for over 14 years. Lisa holds a Bachelor's degree in Biochemistry from Washington State University, obtained in December 2000.
Universal Cells
Universal Cells is a Seattle-based biotech developing, licensing and commercializing stem cell therapies that overcome immune rejection and can be used to create true off-the-shelf therapeutic products. Using the company's proprietary genome editing approach, the company engineers stem cells to prevent expression of polymorphic human leukocyteantigen (HLA) molecules, removing the cause of donor tissue rejection and creating Universal Donor Stem Cells that are compatible with every patient.